These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 23931023

  • 21. Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?
    Carbognin L, Pilotto S, Peretti U, Tortora G, Bria E.
    Expert Opin Investig Drugs; 2016 Jun; 25(6):635-8. PubMed ID: 27054716
    [No Abstract] [Full Text] [Related]

  • 22. [Targeted therapies and radiation therapy in non-small cell lung cancer].
    Rivera S, Quéro L, Wong Hee Kam S, Maylin C, Deutsch E, Hennequin C.
    Cancer Radiother; 2011 Oct; 15(6-7):527-35. PubMed ID: 21885318
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Paradoxical clinical effects of epidermal growth factor receptor-tyrosine kinase inhibitors for acute myelogenous leukemia.
    Hotta K, Kiura K, Takigawa N, Matsuo K, Tabata M, Fujiwara Y, Tanimoto M.
    J Clin Oncol; 2008 Dec 10; 26(35):5826-7; author reply 5827. PubMed ID: 19001344
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Molecular selection for therapy of patients with non-small-cell lung cancer and impaired performance status: has the time come?
    Lara PN.
    Clin Lung Cancer; 2006 Jan 10; 7(4):232-4. PubMed ID: 16512975
    [No Abstract] [Full Text] [Related]

  • 30. [New therapies for non-small cell lung cancer].
    Ostoros G, Kovács G, Szondy K, Döme B.
    Orv Hetil; 2005 May 22; 146(21):1135-41. PubMed ID: 15991677
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Targeted therapies and non-small-cell lung cancer: work in progress?
    Gridelli C.
    Curr Opin Oncol; 2006 Mar 22; 18(2):132-4. PubMed ID: 16462181
    [No Abstract] [Full Text] [Related]

  • 34. Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC.
    Takeda M, Okamoto I, Tsurutani J, Oiso N, Kawada A, Nakagawa K.
    Jpn J Clin Oncol; 2012 Jun 22; 42(6):528-33. PubMed ID: 22457323
    [Abstract] [Full Text] [Related]

  • 35. Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung Cancer.
    Gandara DR, Riess JW, Kelly K, Li T, Mack PC, Lara PN.
    Clin Lung Cancer; 2017 Jan 22; 18(1):1-4. PubMed ID: 28082049
    [Abstract] [Full Text] [Related]

  • 36. Developments in pharmacotherapy for treating metastatic non-small cell lung cancer.
    Rossi A, Sacco PC, Santabarbara G, Sgambato A, Casaluce F, Palazzolo G, Maione P, Gridelli C.
    Expert Opin Pharmacother; 2017 Feb 22; 18(2):151-163. PubMed ID: 28067062
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors.
    Chen YM, Lai CH, Rau KM, Huang CH, Chang HC, Chao TY, Tseng CC, Fang WF, Chen YC, Chung YH, Wang YH, Su MC, Huang KT, Liu SF, Chen HC, Chang YC, Chang YP, Wang CC, Lin MC.
    Lung Cancer; 2016 Aug 22; 98():99-105. PubMed ID: 27393514
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of elderly patients or patients who are performance status 2 (PS2) with advanced Non-Small Cell Lung Cancer without epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) translocations - Still a daily challenge.
    Su C, Zhou F, Shen J, Zhao J, O'Brien M.
    Eur J Cancer; 2017 Sep 22; 83():266-278. PubMed ID: 28763691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.